Biotechnology Industry Market Index
The Biotechnology Industry in the Health Care Sector includes companies primarily engaged in the research, development, manufacturing and/or marketing of products based on genetic analysis and genetic engineering (including companies specializing in protein-based therapeutics to treat human diseases).
The Biotechnology industry index is a market composite index that includes 8 stocks from public trading companies and ADRs with the largest market capitalizations in the Biotechnology industry.
The list of stocks in the Biotechnology industry includes Vertex Pharmaceuticals Inc, Amgen Inc, AbbVie Inc, Incyte Corp, Biogen Inc, Regeneron Pharmaceuticals Inc, Gilead Sciences Inc and Moderna Inc..
1/14/2022 Health Care Sector Biotechnology Industry
$248,506
Change: +0.95%
Open: $245,193
High: $250,318
Low: $242,930
| Vertex Pharmaceuticals Inc (VRTX) |
+3.30%
|
| Amgen Inc (AMGN) |
+1.95%
|
| AbbVie Inc (ABBV) |
+1.76%
|
| Incyte Corp (INCY) |
+1.67%
|
| Biogen Inc (BIIB) |
+1.11%
|
| Biotechnology Industry |
+0.95%
|
| Regeneron Pharmaceuticals Inc (REGN) |
-0.14%
|
| Gilead Sciences Inc (GILD) |
-0.15%
|
| Moderna Inc. (MRNA) |
-2.59%
|
Index Value: $248,506 +0.95%
Volume: 12.27B Average Volume (3 month): 9.49B
Market Capitalization: $232.65T
EBITDA: $28.15T
EPS Basic: $3,596 Diluted: $2,515 Actual: $5,240
EPS Estimation: High $4,953 Medium: $4,442 Low: $3,927
EPS TTM: $10,400
P/E: 23.89
PEG Ratio (5 year Expected): 2.26
Dividend Yield: 2.33%
Dividend Rate: $5,702
Dividend Yield (Forward): 2.47%
Dividend Rate (Forward): $6,152
Shares Outstanding: 1.83T
Book Value: $32,285
Short Ratio: 2.44
Price Target (1 year): $274,811
Volume: 12.27B Average Volume (3 month): 9.49B
Market Capitalization: $232.65T
EBITDA: $28.15T
EPS Basic: $3,596 Diluted: $2,515 Actual: $5,240
EPS Estimation: High $4,953 Medium: $4,442 Low: $3,927
EPS TTM: $10,400
P/E: 23.89
PEG Ratio (5 year Expected): 2.26
Dividend Yield: 2.33%
Dividend Rate: $5,702
Dividend Yield (Forward): 2.47%
Dividend Rate (Forward): $6,152
Shares Outstanding: 1.83T
Book Value: $32,285
Short Ratio: 2.44
Price Target (1 year): $274,811
| Symbol | Security | Price | Gain | Volume | vol. Str. | Weight |
| VRTX | Vertex Pharmaceuticals Inc | 234.06 | +3.30% | 2.18M | 1.17 | 8.23% |
| AMGN | Amgen Inc | 235.36 | +1.95% | 3.01M | 1.08 | 18.33% |
| ABBV | AbbVie Inc | 135.87 | +1.76% | 10.48M | 1.66 | 33.21% |
| INCY | Incyte Corp | 74.88 | +1.67% | 1.55M | 0.69 | 2.29% |
| BIIB | Biogen Inc | 239.30 | +1.11% | 1.77M | 1.13 | 4.86% |
| Biotechnology Industry | 248,506.15 | +0.95% | 12.27B | 1.29 | 11.78% | |
| REGN | Regeneron Pharmaceuticals Inc | 615.24 | -0.14% | 775,147 | 1.03 | 9.15% |
| GILD | Gilead Sciences Inc | 71.77 | -0.15% | 8.16M | 1.15 | 12.45% |
| MRNA | Moderna Inc. | 204.73 | -2.59% | 9.84M | 0.84 | 11.48% |
| Symbol | Security | Market Cap | EPS TTM | P/E | Div Yield | PEG Ratio |
| VRTX | Vertex Pharmaceuticals Inc | 59.51B | $8.33 | 28.10 | 1.13 | |
| AMGN | Amgen Inc | 132.57B | $9.71 | 24.24 | 2.98% | 2.83 |
| ABBV | AbbVie Inc | 240.237B | $3.71 | 36.62 | 3.89% | 2.23 |
| INCY | Incyte Corp | 16.54B | $2.41 | 31.07 | 1.42 | |
| BIIB | Biogen Inc | 35.151B | $10.22 | 23.41 | -1.81 | |
| Biotechnology Industry | $232.65T | $10,400 | 23.89 | 2.33% | 2.26 | |
| REGN | Regeneron Pharmaceuticals Inc | 66.165B | $62.63 | 9.82 | 0.69 | |
| GILD | Gilead Sciences Inc | 90.027B | $5.86 | 12.25 | 3.91% | 6.78 |
| MRNA | Moderna Inc. | 83.008B | N/A | N/A | 0.50 | |
Back to Market Summary